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Background. We evaluated the extent to which hospital characteristics, infection control practices, and compliance with preven-
tion bundles impacted multidrug-resistant organism (MDRO) infections in Thai hospitals.
Methods. From 1 January 2014 to 30 November 2014, we surveyed all Thai hospitals with an intensive care unit and ≥250 beds. 
Infection control practices for methicillin-resistant Staphylococcus aureus (MRSA) and multidrug-resistant Acinetobacter baumannii 
(MDR-AB) were assessed. Linear regression was used to examine associations between hospital characteristics and prevention bun-
dle compliance and changes in MDRO infection rates.
Results. A total of 212 of 245 (86.5%) eligible hospitals responded. Most hospitals regularly used several fundamental infec-
tion control practices for MRSA and MDR-AB (ie, contact precautions, private room/cohorting, hand hygiene, environmental 
cleaning, and antibiotic stewardship); advanced infection control practices (ie, active surveillance, chlorhexidine bathing, decol-
onization for MRSA, and hydrogen peroxide vaporizer for MDR-AB) were used less commonly. Facilities with ≥75% compliance 
with the MRSA prevention bundle experienced a 17.4% reduction in MRSA rates (P = .03). Although the presence of environ-
mental cleaning services (41.3% reduction, P = .01) and a microbiology laboratory (82.8% reduction, P = .02) were among char-
acteristics associated with decreases in MDR-AB rates, greater compliance with the MDR-AB prevention bundle did not lead to 
reductions in MDR-AB rates.
Conclusions. Although fundamental MRSA and MDR-AB control practices are used regularly in most Thai hospitals, compli-
ance with more comprehensive bundled prevention approaches is suboptimal. Improving compliance with bundled infection pre-
vention approaches and promoting the integration of certain hospital factors into infection control efforts may help reduce MDRO 
infections in Thai hospitals.
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Multidrug-resistant gram-positive and gram-negative path-
ogens are increasing worldwide and pose a major challenge 
for healthcare institutions [1–4]. In Southeast Asia, methi-
cillin-resistant Staphylococcus aureus (MRSA) is the major 
resistant gram-positive pathogen, while multidrug-resistant 
Acinetobacter baumannii (MDR-AB) has become the most 
common resistant gram-negative pathogen in several patient 
populations [5, 6]. In Thailand, the National Antimicrobial 
Resistance Surveillance Thailand program established a national 
commitment to multidrug-resistant organism (MDRO) sur-
veillance and patient safety over the past decade [7–10]. The 
hospital prevalence of MRSA in Thailand has been estimated 
to be 26% for colonization and infection, with higher estimates 
(65%) among intensive care unit (ICU) patients [7, 8].
Infection control interventions such as contact precautions, 
patient cohorting, hand hygiene, environmental cleaning, and the 
presence of an antimicrobial stewardship program are considered 
essential to prevent the spread of these resistant pathogens [11, 
12]. Assessing the efficacy of individual and bundled infection 
control measures and determining predictors of increased com-
pliance with these practices can add to our knowledge of infection 
prevention and inform policy to help prevent these resistant path-
ogens. We therefore conducted a national survey in Thailand to 
evaluate the impact of infection prevention practices used to pre-
vent MRSA and MDR-AB, and to investigate the extent to which 
compliance with prevention practices impacts these pathogens.
METHODS
Survey Instrument
From 1 January 2014 to 30 November 2014, we surveyed all 
hospitals in Thailand with an ICU and at least 250 hospitals 
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beds (n  =  245). The list of hospitals that met our inclusion 
criteria was obtained from the Ministry of Public Health of 
Thailand. The survey instrument was first developed by Krein 
et  al and Saint et  al [13–15]. The survey was translated into 
Thai by an experienced hospital epidemiologist (A. A.). The 
survey assessed facility-wide, personnel, and infection control 
program characteristics. Infection control practices specific to 
MDROs inclusive of MRSA and MDR-AB were assessed.
The lead infection preventionist for each hospital was inter-
viewed to determine the frequency of various infection pre-
vention practices being used as well as the level of compliance 
to MRSA and MDR-AB prevention practices. Infection pre-
ventionists were asked about the frequency with which their 
hospital utilized the infection-specific prevention practices on 
a 5-point Likert scale for 5 fundamental (ie, contact precau-
tions, private room/cohorting, hand hygiene, environmental 
cleaning, and antibiotic stewardship) and 4 advanced (ie, active 
surveillance for MRSA and MDR-AB, chlorhexidine bathing, 
decolonization for MRSA, and hydrogen peroxide vaporizer for 
MDR-AB) infection control measures. Responses of 4 (almost 
always) or 5 (always) were coded as “regular use” and the dichot-
omized variables were used in all analyses. For the compliance 
questions, infection preventionists were asked how often their 
hospital complied with the given practices, alone and as a bun-
dle (scaled as 1 = “100%” to 6 = “No monitoring compliance”). 
Responses of 1 or 2 (75%–99%) were coded as high bundle 
compliance for all analyses. For MRSA, the bundled practices 
consisted of hand hygiene, contact isolation, antibiotic steward-
ship, patient cohorting, and at least 1 of the following: active 
surveillance, decolonization with mupirocin, chlorhexidine 
gluconate bathing, or environmental cleaning. For MDR-AB, 
the bundled practices consisted of hand hygiene, contact iso-
lation, antibiotic stewardship, patient cohorting, and at least 1 
of the following: active surveillance, environmental cleaning, 
chlorhexidine gluconate bathing, or hydrogen peroxide vapor-
izer. Hospitals reported annual aggregate infection rates for 
MRSA and MDR-AB at 2 time points (12 months before and 
12 months after the implementation of specific infection control 
practices) as the number of cases per 1000 patient-days.
Trained research nurses used the survey instrument to inter-
view the lead infection preventionist at each hospital. Three 
training sessions were held to instruct the 5 research nurses on 
the survey and data collection procedures. The survey instru-
ment was pilot tested in 10 hospitals to ensure the validity, 
reliability, and acceptability of the survey results by 5 research 
nurses; 100% interrater agreement in the responses captured 
was observed in the pilot test. The study was approved by the 
Institutional Review Board at Thammasat University.
Statistical Analysis
Descriptive statistics are given for all pertinent survey ques-
tions. Multivariable logistic regression was used to determine 
significant associations between hospital characteristics and 
regular use of MRSA and MDR-AB infection prevention prac-
tices. Multivariable linear regression models were used to assess 
the associations between high compliance with the MRSA and 
MDR-AB prevention bundles and relative reductions in the 
respective infection rates. Hospital characteristics considered 
included type of ownership, number of acute care beds, affili-
ation with a medical school, presence of hospitalists, involve-
ment in a collaborative to reduce hospital infections, support 
of the infection control program from leadership, presence of 
a hospital epidemiologist, total full-time equivalent of all infec-
tion preventionists, and whether the lead infection prevention-
ist is certified in infection control. Additionally, whether or not 
the hospital has an infectious diseases physician, presence of 
environmental cleaning services, facilities maintenance depart-
ment, or microbiology laboratory were also included as covar-
iates if they were statistically significant in a bivariable model. 
Multivariable linear regression models were used to assess rela-
tive reductions in MRSA and MDR-AB rates. In addition to the 
questions mentioned above, the relative reduction models were 
additionally adjusted for selected infection prevention prac-
tices. All models were adjusted for whether or not the hospital 
has an established surveillance system for monitoring infection 
rates. All analyses were conducted using SAS software version 
9.4 (SAS Institute, Cary, North Carolina).
RESULTS
Of the 245 eligible hospitals, 212 (86.5%) responded to our 
survey. General hospital and infection control characteristics 
are shown in Table 1. Nearly 97% of hospitals reported having 
hospitalists, 94.8% had a microbiology laboratory, and 92.5% 
had an infection preventionist who was certified in infection 
control. Approximately half of all hospitals were affiliated with 
a medical school (52.4%), had infection disease specialists 
(50.9%), and were involved in a healthcare-associated infection 
(HAI) collaborative (49.5%).
The percentages of regular use of fundamental and advanced 
infection control measures for patients infected with MRSA 
and MDR-AB are shown in Table 2. The majority of hospitals 
regularly used contact precautions (77.4%), private rooms or 
cohorting (72.2%), appropriate hand hygiene (84.0%), and envi-
ronmental cleaning of patients’ room and surroundings (85.4%). 
In this national cohort, overall use of an antibiotic stewardship 
program was observed in more than half of the hospitals sur-
veyed (54.2%). Only 37.3% of facilities regularly used active 
surveillance cultures for colonization of MRSA and 22.6% reg-
ularly decolonized the nose and skin of patients colonized with 
MRSA prior to surgery. Fewer hospitals regularly used active 
surveillance culturing (36.3%), chlorhexidine bathing for the 
patients infected with MDR-AB (31.1%), or hydrogen peroxide 
room disinfection system of the MDR-AB–infected patients’ 
room and surroundings for terminal disinfection (21.2%).
The odds ratios and 95% confidence intervals for select char-
acteristics associated with MDRO prevention practices are also 
presented in Table 2. For MRSA, involvement in an HAI collab-
orative, leadership support of infection control, and the presence 
of a facilities maintenance department were all significantly asso-
ciated with increased active surveillance cultures for colonization. 
Leadership support of infection control was significantly associated 
with increased regular use of the following 5 MDR-AB infection 
prevention practices: contact precautions, private rooms or cohort-
ing of patients, hand hygiene, environmental cleaning of infected 
patients’ room and surroundings, and chlorhexidine bathing.
Compliance rates for MRSA and MDR-AB prevention prac-
tices were very similar. Nearly two-thirds of responding hos-
pitals reported ≥75% compliance using hand hygiene (65.6% 
for MRSA, 64.2% for MDR-AB). More than 60% of hospitals 
reported compliance with hand hygiene and contact isolation in 
patients with MRSA (62.3%) or MDR-AB (61.3%). Compliance 
with antibiotic stewardship (45.8% for both MRSA and 
MDR-AB) and patient cohorting (40.1% for MRSA, 42% for 
MDR-AB) was lower. Nearly 40% of hospitals reported at least 
75% compliance for the MRSA (37.0%) and MDR-AB (38.7%) 
prevention bundles.
Multivariable model results for changes in MRSA and 
MDR-AB infection rates are presented in Tables 3 and 4, 
respectively. Facilities with ≥75% compliance with the preven-
tion bundle for MRSA experienced on average a 17.4% reduc-
tion in MRSA rates (P  =  .03). Involvement in a collaborative 
to reduce HAI was also associated with a reduction in MRSA 
rates (18.9%, P = .01). Although several individual factors were 
associated with changes in MDR-AB rates (presence of envi-
ronmental cleaning services [41.3% reduction, P =  .01], facil-
ities maintenance department [33.3% reduction, P = .04], and 
microbiology laboratory [82.8% reduction, P = .02]), achieving 
high compliance with the prevention bundle for MDR-AB was 
not significantly associated with MDR-AB reductions.
DISCUSSION
Several important findings emerged from this national sur-
vey in Thailand. First, although most hospitals reported reg-
ular use of fundamental infection control measures to reduce 
MRSA and MDR-AB transmission, advanced infection control 
measures were less commonly performed. Second, we noticed 
that compliance with prevention bundles—consisting of fun-
damental and advanced infection control measures—to con-
tain both MRSA and MDR-AB was less than optimal. This is 
especially important as infection prevention interventions have 
been reported effective only when compliance is high [16, 17]. 
Third, hospitals reporting high compliance with the prevention 
bundle for MRSA were more successful at reducing MRSA. 
Additionally, hospitals with better infection control infrastruc-
ture and support were more likely to reduce MDR-AB. Taken 
together, these findings suggest the need for continued educa-
tion and process surveillance to ensure compliance with infec-
tion control measures to prevent MDRO infections in Thailand.
A previous study, using similar methodology, conducted by 
Apisarnthanarak and colleagues found that medical school affil-
iation and participating in an HAI collaborative were associated 
with infection control policies to prevent MRSA, and having 
a physician as the head of infection control, strong leadership 
support of the infection control program, participating in a 
collaborative effort to reduce hospital infections, and a strong 
organizational safety culture were associated with infection con-
trol policies to prevent MDR-AB [18]. In the current study, we 
identified a similar rate of implementing fundamental infection 
control measures with slight improvement in advanced infection 
control measure implementation. Our current findings confirm 
that leadership support of infection control programs and par-
ticipation in a collaborative effort to reduce hospital infections 
remains crucial for MRSA and MDR-AB prevention. We also 
found that the lead infection preventionist being certified in 
infection control was associated with increased compliance to 
advanced infection control practices to prevent MDR-AB. This 
could be partly explained by the governmental Thai curric-
ulum created in 2000 intended to provide formal training for 
postgraduate physicians who plan to head infection control. 
Whether this advanced training could impact competency of 
Table 1. Respondent Hospital Characteristics (n = 212)
Characteristic No. (%)
Region
 Northern 14 (6.6)
 Southern 20 (9.4)
 Central 106 (50.0)
 Northeastern 36 (17.0)
 Eastern 22 (10.4)
 Western 14 (6.6)
Facility ownership
 Private 44 (20.8)
 Government-owned 148 (69.8)
 Military 20 (9.4)
Total No. of acute care hospital beds (including ICU), mean 
± SD
545.9 ± 468.5
Medical school affiliation 111 (52.4)
Infectious diseases specialist(s) 108 (50.9)
Environmental cleaning services 130 (61.3)
Facilities maintenance department 144 (67.9)
Microbiology laboratory 201 (94.8)
Hospitalists 205 (96.7)
HAI collaborative 105 (49.5)
Good/excellent support of infection control program 135 (63.7)
Hospital epidemiologist 83 (39.2)
Total FTE for all infection preventionists, mean ± SD 3.5 ± 3.4
Lead infection preventionist certified in infection control 196 (92.5)
Antibiotic stewardshipa 115 (54.2)
Data are shown as No. (%) unless otherwise indicated.Abbreviations: FTE, full-time equiv-
alent; HAI, healthcare-associated infection; ICU, intensive care unit.aFor prevention of mul-
tidrug-resistant Acinetobacter baumannii.
healthcare epidemiology programs in resource-limited settings 
should be further assessed [19–21].
Increasing compliance levels for utilizing infection 
control measures has been emphasized as a key component for 
success-ful outcomes in several guidelines for MDRO 
prevention efforts [22–24]. However, the optimal 
compliance level for success-ful MDRO control is unknown. 
In this survey, we found that 
compliance rates for the various MRSA and MDR-AB prevention 
practices were very similar and ranged from approximately 40% 
to >75%. Not surprisingly, advanced infection control measures 
had a lower compliance rate than fundamental measures. Of 
interest, facilities with ≥75% compliance with fundamental infec-
tion control measures plus either active surveillance, decoloniza-
tion with mupirocin, chlorhexidine bathing, or environmental 
Table 2. Characteristics Significantly Associated With Regular Use of Specific Methicillin-Resistant Staphylococcus aureus and Multidrug-Resistant 
Acinetobacter baumannii Prevention Practices





Practices specific to MRSA prevention
Medical school affiliation 0.35 (.17–.73) .005 Active surveillance 
cultures
37.30%
Facilities maintenance department 8.40 (3.44–20.52) <.0001
HAI collaborative 2.35 (1.16–4.73) .02
Good/excellent support of infection 
control program
2.09 (1.04–4.20) .04
Facilities maintenance department 2.82 (1.07–7.41) .04 Decolonization of the 
nose and skin in 
colonized patients 
prior to surgical 
procedure
22.60%
HAI collaborative 2.46 (1.12–5.37) .02
Practices specific to MDR-AB prevention
Facilities maintenance department 2.39 (1.06–5.37) .04 Contact precautions 
while caring for 
infected patients
77.40%
Good/excellent support of infection 
control program
2.20 (1.09–4.46) .03
Lead infection preventionist certified 
in infection control
4.19 (1.26–13.96) .02




Private 4.22 (1.38–12.93) .01
Government-owned Ref
Military 2.11 (.61–7.33) .24
Good/excellent support of infection 
control program
2.37 (1.22–4.61) .01
Lead infection preventionist certified in 
infection control
3.41 (1.11–11.41) .05
Involved with a collaborative effort to 
reduce HAI
2.86 (1.13–7.22) .03 Appropriate hand 
hygiene
84.00%
Good/excellent support of infection 
control program
3.33 (1.46–7.62) .004
Lead infection preventionist certified in 
infection control
5.74 (1.43–23.05) .01 Antibiotic stewardship 
program
54.20%
Good/excellent support of infection 
control program
3.97 (1.70–9.27) .001 Environmental 
cleaning of infected 
patients’ room and 
surroundings
85.40%
Good/excellent support of infection 
control program
2.21 (1.10–4.46) .03 Chlorhexidine bathing 
for infected patients
31.10%






Medical school affiliation 0.36 (.17–.74) .01 Active surveillance 
cultures
36.30%
Facilities maintenance department 3.63 (1.57–8.43) .003
HAI collaborative 2.50 (1.24–5.03) .01
Abbreviations: CI, confidence interval; HAI, healthcare-associated infection; MDR-AB, multidrug-resistant Acinetobacter baumannii; MRSA, methicillin-resistant Staphylococcus aureus; OR, 
odds ratio.
cleaning for MRSA prevention experienced on average a 17.4% 
reduction in MRSA rates over a year, while having sophisticated 
infrastructure facility factors (eg, environmental cleaning ser-
vices, facilities maintenance department division, microbiol-
ogy laboratory) were associated with MDR-AB rate reductions. 
These findings imply the need to have high-level compliance for 
both fundamental and advanced infection control measures for 
successful MRSA containment, while environmental cleaning is 
seemingly crucial for the control of MDR-AB. As prior studies 
have demonstrated the potential roles of airborne and water-
borne transmission in MDR-AB infections [25–28], hospitals 
better equipped to limit these transmission routes due to better 
facility infrastructure and resources (eg, having a facilities main-
tenance department division and microbiology laboratory) will 
likely achieve better infection control for MDR-AB than hospi-
tals with limited resources.
Our study has several important limitations. First, because 
the response rate was <100%, our results are susceptible to 
nonresponse bias. Although we achieved a very high response 
rate, our findings may not be generalizable to all hospitals 
in Thailand. Second, as we relied on self-reported data from 
the lead infection preventionist to determine the frequency 
of various infection control practices being used, there is a 
potential for response bias. Third, MDRO infection rates at 
2 time points were based on reported estimates from the lead 
infection preventionist at each hospital. Absent longitudinal 
infection rate data, reported rates in our study are prone to 
response bias. Finally, we did not have access to (and thus 
could not adjust for) patient-level or hospital case-mix data. 
As such, our regression adjustments could be biased because 
of unmeasured confounding, and our results can only be 
interpreted as providing evidence for associations rather than 
causal mechanisms.
Despite these limitations, our study identified several areas 
of focus for quality improvement efforts for MDRO infection 
prevention in Thai hospitals. Key quality improvement tar-
gets include education in implementing bundled prevention 
approaches that include advanced infection control measures. 
Continued government support for formal training on infec-
tion prevention for postgraduate physicians who become lead 
infection preventionists, enhancement of facility factors and 
safety structure, and infection control compliance level mon-
itoring for both fundamental and advanced infection control 
measures are essential components to help reduce the burden of 
MRSA and MDR-AB in Thai hospitals.
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Table  3. Rates of Methicillin-Resistant Staphylococcus aureus— 
Multivariable Regression
Characteristic Estimate (95% CI) P Value
Type of ownership
Government-owned Ref
Private –0.0158 (–.2122 to .1807) .87
Military –0.1358 (–.3902 to .1186) .30
No. of acute care beds 0.0001 (–.0002 to .0003) .62
Medical school affiliation –0.115 (–.2699 to .04) .15
Hospitalists 0.2999 (–.1151 to .715) .16
HAI collaborative –0.1889 (–.3397 to –.0381) .01
Good/excellent support of infection 
control program
–0.1077 (–.2628 to .0474) .17
Hospital epidemiologist 0.257 (.103–.411) .001
Total FTE for all infection preventionists –0.0176 (–.0426 to. 0074) .17
Lead infection preventionist certified in 
infection control
–0.0325 (–.3072 to .2421) .82
Gram-positive bacteria bundle: hand 
hygiene + contact isolation + antibi-
otic stewardship + patient cohorting 
+ at least 1 of the following: active 
surveillance, decolonization with 
mupirocin, chlorhexidine gluconate 
bathing, or environmental cleaning
–0.1737 (–.3279 to –.0195) .03
Abbreviations: CI, confidence interval; FTE, full-time equivalent; HAI, healthcare-associated 
infection.
Table  4. Rates of Multidrug-Resistant Acinetobacter baumannii— 
Multivariable Regression
Characteristic Estimate (95% CI) P Value
Type of ownership
 Government-owned Ref
Private –0.0042 (–.3871 to .3786) .98
Military 0.4359 (–.0389 to .9108) .07
No. of acute care beds 0.0003 (–.0001 to .0007) .10
Medical school affiliation 0.128 (–.1806 to .4365) .42
Environmental cleaning service –0.4126 (–.7353 to –.09) .01
Facilities maintenance 
department
–0.3331 (–.651 to –.0153) .04
Microbiology laboratory –0.828 (–1.4996 to –.1565) .02
Hospitalists 0.4603 (–.3563 to 1.277) .27
HAI collaborative –0.11 (–.4141 to .1941) .48
Good/excellent support of infec-
tion control program
0.1502 (–.1409 to .4412) .31
Hospital epidemiologist –0.134 (–.4252 to .1572) .37
Total FTE for all infection 
preventionists
–0.0267 (–.0747 to .0214) .28
Lead infection preventionist certi-
fied in infection control
0.0767 (–.4493 to .6028) .77
Gram-negative bacteria bundle: 
hand hygiene + contact isola-
tion + antibiotic stewardship + 
patient cohorting + at least 1 
of active surveillance, environ-
mental cleaning, chlorhexidine 
gluconate bathing, or hydrogen 
peroxide vaporizer
–0.1572 (–.4534 to .1389) .30
Abbreviations: CI, confidence interval; FTE, full-time equivalent; HAI, healthcare-associated 
infection.
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